RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

David E.I. Pyott

A collection of news and information related to David E.I. Pyott published by this site and its partners.

Top David E.I. Pyott Articles

Displaying items 1-11
  • Allergan sale to Actavis complete; CEO David Pyott is leaving

    Allergan sale to Actavis complete; CEO David Pyott is leaving
    The $70-billion purchase of Botox maker Allergan Inc. of Irvine by Irish company Actavis has closed, Actavis confirmed Tuesday. Allergan’s longtime leader, David E.I. Pyott, will not have a position in the new company, which will be called...
  • Office Depot CEO could walk with $39 million after merger

    Office Depot CEO could walk with $39 million after merger
    After less than two years on the job, Office Depot CEO Roland Smith could receive $39 million if the Staples-Office Depot merger is finalized, executive pay experts say. Smith, 60, would leave with a $7 million severance, roughly twice his salary and...
  • Few Allergan execs to keep top jobs in Actavis takeover

    Few Allergan execs to keep top jobs in Actavis takeover
    The soon-to-be owner of Irvine-based Allergan Inc. announced sweeping leadership changes that pass over many current executives including the Botox maker's CEO. Irish pharmaceutical giant Actavis expects to finalize its $66-billion acquisition in the...
  • Allergan sale to Actavis thwarts takeover attempt by Valeant

    Allergan sale to Actavis thwarts takeover attempt by Valeant
    Botox maker Allergan Inc., an Irvine company that started as a purveyor of eye drops and grew into one of the most respected pharmaceutical companies in the country, agreed to be acquired by Irish firm Actavis for $66 billion. The deal thwarts a...
  • Valeant says it's willing to raise offer for Allergan to $200 a share

    Valeant says it's willing to raise offer for Allergan to $200 a share
    As shareholders of Botox maker Allergan Inc. prepare for a vote on the company's future, a Canadian suitor said it's willing to increase its offer to buy the Irvine firm. J. Michael Pearson, chief executive of Valeant Pharmaceuticals International Inc.,...
  • Allergan, embroiled in takeover battle, raises its profit forecast

    Allergan, embroiled in takeover battle, raises its profit forecast
    Botox maker Allergan lifted its profit outlook Thursday as it tries to stave off a takeover attempt from a Canadian rival. The Irvine-based drug maker said it expects to earn between $1.76 and $1.78 a share during the third quarter, up from its previous...
  • Allergan board rejects latest Valeant offer

    The board of Botox maker Allergan Inc. unanimously rejected an increased buyout offer from a Canadian pharmaceutical company as the closely watched acquisition effort showed no signs of a resolution. Valeant Pharmaceuticals International Inc. last month...
  • Ackman, Valeant partner in bid to buy Botox maker Allergan

     Ackman, Valeant partner in bid to buy Botox maker Allergan
    Activist investor Bill Ackman is partnering with a Canadian pharmaceutical company in an effort to buy Allergan Inc., the Irvine company that makes the popular wrinkle treatment Botox. Ackman and Valeant Pharmaceuticals International Inc. have already...
  • Allergan stock climbs amid $46-billion bid

     Allergan stock climbs amid $46-billion bid
    Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman moved forward with their plans to acquire Botox maker Allergan Inc., offering shareholders about $46 billion and touching off what could be a contentious fight....
  • Valeant hikes its takeover offer for Allergan

    For weeks, Valeant Pharmaceuticals had promised a better offer for Botox maker Allergan, but its renewed cash-and-stock offer fell flat with investors and analysts. After Irvine-based Allergan Inc. rejected a $46-billion offer earlier this month, the...
  • Allergan co-founder speaks out against Valeant takeover

    The board and chief executive of Irvine takeover target Allergan Inc. heard a voice from the past Tuesday at the company's annual meeting of shareholders. Gavin S. Herbert, Allergan's co-founder and former chairman, urged the company's directors to...